Use of 177Lu-dotatate in the treatment of iodine refractory thyroid carcinomas.

Related Articles Use of 177Lu-dotatate in the treatment of iodine refractory thyroid carcinomas. Rev Esp Med Nucl Imagen Mol. 2017 Mar – Apr;36(2):116-119 Authors: Oliván-Sasot P, Falgás-Lacueva M, García-Sánchez J, Vera-Pinto V, Olivas-Arroyo C, Bello-Arques P Abstract In a patient with a differentiated thyroid cancer the standard treatment protocol to be followed is surgery, ablation of thyroid remnants with 131Iodine (131I), and TSH suppression. However, the treatment with 131I is not effective in some cases, and it no longer becomes a therapeutic option due to cell de-differentiation with loss of 131I uptake. Systemic treatment can be used as other options,…
Origen: Use of 177Lu-dotatate in the treatment of iodine refractory thyroid carcinomas. – PubMed